Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series
- PMID: 32389697
- PMCID: PMC7204750
- DOI: 10.1016/j.bbi.2020.05.022
Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series
Abstract
Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).
Keywords: Autoimmune; COVID-19; Encephalitis; Plasmapheresis.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
